A comparative study of reliability of self report of tobacco use among patients with bipolar and somatoform disorders
- 1*,
- 2,
- 2,
- 2
- 1Department of Psychiatry and De-addiction, Lady Hardinge Medical College and Smt. Sucheta Kriplani Hospital.
- 2Department of Psychiatry, All India Institute of Medical Sciences, New Delhi, India Research Paper.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Yatan Pal Singh Balhara
Department of Psychiatry and De-addiction, Lady Hardinge Medical College and Smt. Sucheta Kriplani Hospital.
Copyright: © 2011 The Author(s). This is an open access article.
Abstract
Objective: To compare the use and reliability of self-reported tobacco use (both smoked and smokeless) among patients with bipolar disorder and somatoform disorders. Materials and Methods: The study was conducted at psychiatry out-patient department of a tertiary care hospital. A total of 50 consecutive patients were recruited. The subjects were asked about the use of tobacco products (smoked as well as smokeless) over the past one week. Those reporting affi rmatively in response to the question were assessed using Fagerstrom Test for Nicotine Dependence (FTND) scales. Quantitative urinary cotinine levels were assessed using Enzyme-linked immunosorbent assay (ELISA). Results: Calculation of Cohen’s kappa using cross tabulation revealed discordance between the self-reported use of smoked as well as smokeless tobacco products in both the groups. Analysis using the lower cut off of 50 ng/ ml also revealed discordance between the self-reported tobacco use (smoked as well as smokeless) for both the groups. Conclusions: The reliability of self-report is questionable among both these groups for smoking as well as smokeless tobacco products.
Keywords
Subject
Readers Also Viewed
Clinical Outcomes and Management of Post-varicocelectomy on Male Fertility: A Comprehensive Review
Mohammad Akbar Hossain
Jan 1, 2026
Exploring Interleukin-6 Inhibitor Antibodies in Combatting SARS-CoV-2 and its Mutated Variants: Challenges and Future Directions
Mohammed Ali Bakkari, Gassem Ghoal, Fahad Y. Sabei
Jan 1, 2025
Pharmacogenomics Meets Generative AI: Transforming Clinical Trial Design with Large Language Models
Annisa Fatharani, Ali Alsayegh
Jan 1, 2026